From the Department of Pediatrics, Etlik City Hospital, Ankara, Turkey.
Exp Clin Transplant. 2024 Feb;22(2):129-136. doi: 10.6002/ect.2023.0075. Epub 2023 Jul 12.
Vitamin D deficiency is common in pediatric chronic liver disease despite oral replacement. We evaluated vitamin D deficiency before and after liver transplant and the relationship between posttransplant and pretransplant vitamin D deficiency and graft rejection.
Pediatric recipients with chronic liver disease (N =138) were divided into 4 groups: cholestatic liver diseases, cirrhosis, metabolic disorders, and acute liver failure. Pretransplant and posttransplant vitamin D levels, liver function tests, Pediatric End-Stage Liver Disease scores, rejection activity index scores by graft liver biopsy, and posttransplant patient survival were recorded.
There were 62 (45%) female and 76 (55%) male participants (mean transplant age, 6.1 ± 5.6 years). Pretransplant mean available vitamin D of 90 patients was 25.2 ± 20.9 ng/mL, with 36 (40%) within reference range. Posttransplant level for 109 patients was 27.3 ± 18 ng/mL, with 64 (58.7%) within reference range. Pretransplant and posttransplant levels were available for 61 patients, and mean pretransplant levels were lower than posttransplant levels (23.7 ± 19.3 vs 28.3 ± 16.9 ng/mL; P = .01). Patients with cholestatic liver disease had lower pretransplant vitamin D levels (P = .04), which disappeared after transplant. Pretransplant vitamin D levels were positively correlated with serum albumin levels (r = 0.20) in all patients and negatively correlated with total/direct bilirubin (r = 0.29 and r = -0.30) in those with liver diseases and cirrhosis. No correlations were found between pretransplant vitamin D levels and Pediatric End-Stage Liver Disease scores, rejection activity index scores, and posttransplant mortality.
Vitamin D deficiency is prevalent in pediatric chronic liver disease before and after transplant, especially for cholestatic liver diseases. However, no association between vitamin D levels and liver graft rejection or patient survival was noted. We recommend close monitoring and individualized vitamin D supplementation before and after liver transplant.
尽管进行了口服补充,小儿慢性肝病仍普遍存在维生素 D 缺乏。我们评估了肝移植前后的维生素 D 缺乏情况,并研究了移植后和移植前维生素 D 缺乏与移植物排斥之间的关系。
将 138 例患有慢性肝病的儿科受者分为 4 组:胆汁淤积性肝病、肝硬化、代谢紊乱和急性肝衰竭。记录了移植前和移植后的维生素 D 水平、肝功能检查、儿科终末期肝病评分、肝移植活检的排斥活动指数评分以及移植后患者的存活率。
共有 62 名(45%)女性和 76 名(55%)男性参与者(平均移植年龄为 6.1 ± 5.6 岁)。90 名患者的移植前平均可利用维生素 D 为 25.2 ± 20.9ng/ml,其中 36 名(40%)在参考范围内。109 名患者的移植后水平为 27.3 ± 18ng/ml,其中 64 名(58.7%)在参考范围内。61 名患者的移植前和移植后水平均可用,且平均移植前水平低于移植后水平(23.7 ± 19.3 vs 28.3 ± 16.9ng/ml;P =.01)。胆汁淤积性肝病患者的移植前维生素 D 水平较低(P =.04),但移植后水平恢复正常。所有患者的移植前维生素 D 水平与血清白蛋白水平呈正相关(r = 0.20),而患有肝病和肝硬化的患者中,其与总胆红素/直接胆红素呈负相关(r = 0.29 和 r = -0.30)。在移植前维生素 D 水平与儿科终末期肝病评分、排斥活动指数评分和移植后死亡率之间未发现相关性。
小儿慢性肝病患者在肝移植前后均普遍存在维生素 D 缺乏,尤其是胆汁淤积性肝病患者。然而,维生素 D 水平与肝移植物排斥或患者存活率之间无关联。我们建议在肝移植前后密切监测并个体化补充维生素 D。